Medications for Appendicitis

6 results
Fresenius Kabi USA, LLC
Usage: Piperacillin and tazobactam for injection is indicated for treating various infections in adults and pediatric patients (2 months and older), including intra-abdominal infections, nosocomial pneumonia, skin infections, female pelvic infections, and moderate community-acquired pneumonia, particularly caused by beta-lactamase producing bacteria.
Avenacy Inc.
Usage: Piperacillin and tazobactam is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin infections, female pelvic infections, and community-acquired pneumonia in patients aged 2 months and older, primarily caused by specific beta-lactamase producing bacteria. It aims to reduce drug-resistant bacteria development.
Sandoz Inc
Usage: Piperacillin and tazobactam for injection is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections, and moderate community-acquired pneumonia in adults and pediatric patients. It targets infections caused by beta-lactamase producing bacteria, including specific strains of E. coli and Staphylococcus aureus.
Eugia US LLC
Usage: Piperacillin and tazobactam injection is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections, and moderate community-acquired pneumonia in adults and pediatric patients (≥2 months) caused by specific beta-lactamase producing bacteria.
WG Critical Care, LLC
Usage: Piperacillin and tazobactam is indicated for treating various infections in adults and pediatric patients (≥2 months), including intra-abdominal infections, nosocomial pneumonia, skin infections, female pelvic infections, and moderate community-acquired pneumonia, caused by specific beta-lactamase producing bacteria.
Sagent Pharmaceuticals
Usage: Piperacillin and Tazobactam for Injection is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections, and moderate community-acquired pneumonia in adults and pediatric patients (2 months and older), primarily targeting beta-lactamase producing bacteria.